Pharmaceutical Technology, May 2014 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-02-2014
Volume 38
Issue 5

Click the title above to open the Pharmaceutical Technology May 2014 issue in an interactive PDF format.

External Link - PharmTech_NA_May2014.pdf

Articles in this issue
Extractables and Leachables Testing
Extractables and Leachables Testing
NEW_Bruker-841583-1408523195102.jpg
Mass Spectrometer Enhances Performance in Protein Analysis
Data Integrity in the Analytical Laboratory
Data Integrity in the Analytical Laboratory
Q&A with Tony Mitchell, Pharma Tech Industries
Q&A with Tony Mitchell, Pharma Tech Industries
Schniepp_Susan-841808-1408523059103.jpg
Linking Drug Shortages and Quality Metrics
Achieving Zero-Order Release Kinetics Using Multi-Step Diffusion-Based Drug Delivery
Achieving Zero-Order Release Kinetics Using Multi-Step Diffusion-Based Drug Delivery
Milmo_Sean-842039-1408522872703.jpg
EU Steps Up Inspection Efforts
NEW_Aggregates_Sizer-841581-1408523200760.jpg
Aggregation System Improves Analysis of Sub-Visible Particles
web_faiz_kermani-842118-1408522803048.png
Boosting New Antibiotic Drug Development in Europe
Freeze Drying Protein Formulations
Freeze Drying Protein Formulations
Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations
Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations
WEB_SiegfriedSchmitt_New-841842-1408523030349.jpg
Quality-Technical Agreements
Data Management in Manufacturing
peters_rita-842068-1408522852351.jpg
Biopharma Takes a Nervous Glance Over Its Shoulder
Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty
Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty
Recent Videos
Behind the Headlines, Episode 10
Jens Schmidt, associate director MSAT at Lonza
Related Content
Movement towards the intended goal. Moving forward, step by step. Labor and aspiration. Motivation, self-development. Business strategic planning, risk management. New opportunities. Achieve. | Image Credit: ©Andrii Yalanskyi – Stock.Adobe.com

Steps to Process Development Optimization

Susan Haigney
February 4th 2025
Article

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

3d rendering of Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells | Image Credit: © Love Employee - © Love Employee- stock.adobe.com

Advancing ADCs to the Next Level

Feliza Mirasol
February 4th 2025
Article

CDMOs who have integrated technologies can help further the advancement of ADC development.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Alvogen Recalls Fentanyl Transdermal System

Susan Haigney
February 3rd 2025
Article

The company is recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because of possible multi-stacking of patches.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

EMA Recommends Eight New Medicines for Approval in January

Patrick Lavery
February 2nd 2025
Article

Another eight medications already authorized in the EU were recommended for extensions of various indications.